Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Total debt minus cash and cash equivalents
Latest
$-156.10M
↓ 28% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive growthFair Value
Average
$-121.89M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-156.10M | +10.1% |
| 2024 | $-173.73M | -81.5% |
| 2023 | $-95.70M | +18.1% |
| 2022 | $-116.80M | -0.3% |
| 2021 | $-116.42M | -8.7% |
| 2020 | $-107.05M | -141.8% |
| 2019 | $-44.28M | +85.6% |
| 2018 | $-307.30M | -574.6% |
| 2017 | $-45.55M | +18.6% |
| 2016 | $-55.97M | - |